Edward "Tad" Stewart

Edward "Tad" Stewart has over 25 years of experience in the biotechnology industry. Edward "Tad" began their career in 1996 as a Manager in the Strategic Health Solutions Group at KPMG US. In 1998, they became Vice President and Founder of Innovative Health Solutions. In 2001, they joined Merrimack Pharmaceuticals as Head of Commercial and President of Merrimack Healthcare Solutions, and later became SVP of Business Development. From 2017 to 2018, they served as Chief Business Officer of Crescendo Biologics Limited, and then as President and CEO of Commense, Inc. from 2018 to 2019. Edward "Tad" then became Chief Business Officer of Ribon Therapeutics from 2019 to 2021, and is currently serving as Chief Business Officer of GRO Biosciences.

Edward "Tad" Stewart received a B.S. in Biology from Bates College and an MBA from Cornell Johnson Graduate School of Management.